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Abstract
Bloodstream forms of Trypanosoma brucei contain a glycosylphosphatidylinositol-specific phospholipase C (GPI-PLC) that
cleaves the GPI-anchor of the variable surface glycoprotein (VSG). Its location in trypanosomes has been controversial. Here,
using confocal microscopy and surface labelling techniques, we show that the GPI-PLC is located exclusively in a linear array
on the outside of the flagellar membrane, close to the flagellar attachment zone, but does not co-localize with the flagellar
attachment zone protein, FAZ1. Consequently, the GPI-PLC and the VSG occupy the same plasma membrane leaflet, which
resolves the topological problem associated with the cleavage reaction if the VSG and the GPI-PLC were on opposite sides
of the membrane. The exterior location requires the enzyme to be tightly regulated to prevent VSG release under basal
conditions. During stimulated VSG release in intact cells, the GPI-PLC did not change location, suggesting that the release
mechanism involves lateral diffusion of the VSG in the plane of the membrane to the fixed position of the GPI-PLC.
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Introduction
The GPI-PLC is present in bloodstream forms of T. brucei
[1,2,3] and in many other eukaryotic cells. The enzyme cleaves the
GPI-anchor of the VSG and other GPI-anchored proteins,
provided the 2-position on the inositol is underivatized, forming
free diacylglycerol in the membrane and, probably, a 1,2-cyclic
phosphate on the inositol ring, which remains attached to the
released VSG [4,5]. This cleavage converts the membrane-bound
form of the VSG (mVSG) to the soluble released form of the VSG
(sVSG) [6]. The conversion can be detected immunologically
because it exposes the cross-reacting determinant (CRD), which
contains the inositol-1,2-cyclic phosphate [6,7].
VSG release can be initiated by calcium ion influx into intact
trypanosomes [8,9] hypotonic lysis of cells, [6,10,11] and by acidic
stress in long slender bloodstream forms [12,13]. These observa-
tions suggested that VSG release is a regulated process involving
calcium ions. Importantly, catalytic activity itself does not require
Ca
2+ [1,3].
The GPI-PLC is only present in metacyclic and bloodstream
stages of the life cycle where the parasite is covered with a VSG
coat [14,15,16]. Procyclic forms do not contain GPI-PLC
enzymatic activity [14,17,18]. The normal cellular functions of
the GPI-PLC in vivo are not completely clear. However, deletion
of both the genes encoding the GPI-PLC and a Zn
2+-metallopro-
tease prevents the proliferation and differentiation of bloodstream
forms of T. brucei into procyclic forms [19]. It would be helpful to
know the exact location of the GPI-PLC under basal, unstimulated
as well as stimulated conditions in order to confirm this function of
the GPI-PLC by a different approach, to determine any other
functions of the GPI-PLC and to investigate the regulation of the
enzyme. This knowledge would be particularly helpful in a cell as
polarized as T. brucei, where functions can be very localized, even
within the same membrane. However, considerable controversy
exists over the location of the GPI-PLC. In fact the following
different locations for the GPI-PLC have been reported:
(1) The plasma membrane [20]
(2) In or enclosed by membranes of the flagellum, cell body and
Golgi [14]
(3) Cytoplasmic face of intracellular vesicles located between the
Golgi and the flagellar pocket [21]
(4) Internal leaflet of the plasma membrane in intact cells but
migrating around the edge of the ruptured membrane in
broken cells to reside, finally, in the external leaflet of the
plasma membrane [22]
(5) External surface of short-stumpy forms [23]
(6) Glycosomes in normal conditions but migrating to the
endoplasmic reticulum in alkaline conditions [24].
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anti-GPI-PLC immunoglobulin G (IgG), 2A6-6 [25] but observed
different locations.
In the present study we determine the location of the GPI-PLC
in a series of experiments that use a new polyclonal rabbit IgG
anti-GPI-PLC antibody, specific for the GPI-PLC and extensively
characterized. This robust antibody has been employed together
with marker probes and antibodies directed against proteins of
known location in conjunction with confocal microscopy, matrix
assisted laser desorption ionization time of flight mass spectrom-
etry (MALDI-TOF MS), non-penetrating surface radio-iodination
and other techniques. The GPI-PLC was found to be located
exclusively in the outer leaflet of the plasma membrane covering
the flagellum and confined to a narrow linear array along the
flagellar attachment zone.
Results
The GPI-PLC was detected in wild-type but not in GPI-
PLC null mutant bloodstream form trypanosomes
The specificity of the anti-GPI-PLC antibody was validated by
Western blotting following SDS-PAGE. Coomassie blue staining
revealed little if any detectable difference between wild-type and
GPI-PLC null mutant cells (Figure 1, panel A, image 1, tracks +/+
and 2/2 respectively). However, the antibody detected a single
protein band at approximately 39 kDa in wild-type cells, which
was absent in the GPI-PLC null mutant cells (Figure 1, panel A,
image 2, tracks +/+ and 2/2 respectively).
The band immunoprecipitated with the anti-GPI-PLC
antibody from wild-type trypanosomes was the GPI-PLC
as shown by MALDI-TOF MS
The GPI-PLC in wild type bloodstream forms of T. brucei was
immunoprecipitated using the anti-GPI-PLC antibody after
extraction of cells with a mild neutral detergent mixture (see
Methods). The immunoprecipitates were subjected to SDS-PAGE
followed by Western blotting. The Coomassie stained gel revealed
the presence of several bands. The two most prominent bands
corresponded to the heavy chain (Mr 55000) and the light chain
(Mr 23000) of IgG and a sharp band at 39000 corresponded to the
Mr of the GPI-PLC (Figure 1, panel B, image 1, track b) which was
absent from the immunosupernatant (Figure 1, panel B, image 1,
track a). Several other weaker bands at higher Mr than the heavy
chain of IgG were also present in the immunoprecipitate. When
the bands from the immunoprecipitate in a replica gel were
transferred to a polyvinylidene difluoride (PVDF) membrane and
probed with the anti-GPI-PLC antibody, only the band corre-
sponding to the GPI-PLC was detected (Figure 1, panel B, image
2, track b). This band was absent from the immunosupernatant
(Figure 1, panel B, image 2, track a). The Coomassie blue stained
band in a gel from a parallel experiment, corresponding to the
39 kDa protein band and recognized by the anti-GPI-PLC
antibody in the Western blot, was cut from the gel, eluted,
digested with trypsin and subjected to MALDI-TOF MS. The
peptides detected were all derived from the GPI-PLC (Figure 1,
panel B, image 3) with 31% sequence coverage, distributed
uniformly throughout the protein.
In addition, MALDI-TOF MS also correctly identified the
peptides in both portions of the intact GPI-PLC-MBP fusion
protein and in the separated GPI-PLC and MBP after cleavage of
the fusion protein (Text S1 and Figure S1).
The GPI-PLC is exposed at the external surface of
bloodstream forms of T. brucei
Immunoprecipitates were prepared from whole wild-type
surface radio-iodinated Molteno Institute antigenic type (MITat)
1.2 cells and analysed by SDS-PAGE and autoradiography. No
radio-labelled GPI-PLC was immunoprecipitated when preim-
mune IgGs were used (Figure 2, track 1). In this case only a very
small amount of contaminating VSG was observed in the
immunoprecipitate, which probably results from the large excess
(approx. 200 fold) of VSG over that of the GPI-PLC in wild-type
cells. No other proteins were detected when preimmune IgGs were
used. In a separate but similar experiment the autoradiogram of
the SDS-PAGE gel, containing the proteins in the anti-GPI-PLC
immunoprecipitates of wild-type cells, displayed a strong band
corresponding to the GPI-PLC as well as strong bands
corresponding to several other proteins (Figure 2, track 3).
However, when the same experiment was performed using GPI-
PLC null-mutant cells, there was no band corresponding to the
GPI-PLC in the autoradiogram (Figure 2, track 2). In addition,
surface labelling of cells did not label the internal protein, tubulin
(Text S1 and Figure S2). These experiments strongly suggest that
the GPI-PLC is exposed to the external face of the plasma
membrane.
The GPI-PLC was detected in wild type bloodstream
forms, both long-slender and short-stumpy types, but
not in null mutant bloodstream forms or in procyclic
forms by immunofluorescence
The GPI-PLC was detected by immunofluorescence using the
anti-GPI-PLC antibody in wild-type bloodstream forms (Figure 3,
panel A) and was absent in GPI-PLC
2/2 bloodstream forms
(Figure 3, panel B) and in procyclic forms (Figure 3, panel C). The
universal presence of the GPI-PLC was particularly striking in all
wild type bloodstream form cells when viewed at low power
magnification where many cells are found in the single field of
view (Figure 3, panel D). Likewise the absence of the GPI-PLC in
GPI-PLC null mutant bloodstream forms was obvious in all cells
within the population in low magnification views (Figure 3, panel
E). The distribution of the GPI-PLC in wild type cells was
Author Summary
African trypanosomes cause sleeping sickness, for which
current therapy is inadequate. The parasite protects its
surface from the host immune system by regularly
switching its surface coat. The glycosylphosphatidylinosi-
tol-PLC only occurs in the bloodstream form, where it
removes the surface coat after it enters the tsetse fly
vector. Activation of the enzyme in the bloodstream would
be fatal for the parasite and it is, therefore, a potential drug
target. However, therapeutic strategies have been ham-
pered by confusion over the location of the GPI-PLC
despite great effort by many labs. We have used a wide
variety of techniques, including one completely novel
method, that exploits the dependence of detection for
partially buried surface proteins on the temperature of
fixation, to identify the location of the GPI-PLC in relation
to other markers unequivocally. All approaches consis-
tently show that the GPI-PLC is located exclusively in the
outer leaflet of the plasma membrane covering the
flagellum, where it is confined to a narrow linear array
adjacent to the flagellar attachment zone. Our data have
resolved the question of how enzyme and substrate meet
and also suggest that chemotherapeutic agents would be
able to target the GPI-PLC in its exterior location.
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PLoS Pathogens | www.plospathogens.org 2 June 2009 | Volume 5 | Issue 6 | e1000468Figure 1. Specificity of the anti-GPI-PLC antibody for the GPI-PLC. Proteins in both wild type GPI-PLC
+/+ and GPI-PLC
2/2 null mutant
trypanosomes were separated by SDS-PAGE on 15% (w/v) polyacrylamide gels and stained with Coomassie blue (panel A, image 1). The protein
bands on replica gels were transferred to a PVDF membrane and probed with 3.9 mg of rabbit IgG anti-GPI-PLC primary antibody, followed by goat
anti-rabbit IgG secondary antibody (panel A, image 2). The GPI-PLC was specifically immunoprecipitated from detergent lysates of whole
bloodstream forms of T. brucei and was subjected to SDS-PAGE (panel B, image 1) and western blotting (panel B, image 2). In a parallel experiment
the indicated 39 kDa protein band was cut from the gel, processed, digested with trypsin and then subjected to MALDI-TOF MS (panel B, image 3). In
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flagellar attachment (Figure 3, panel A). It was never found in
cytoplasmic vesicles, in the regions usually occupied by either the
endoplasmic reticulum or the glycosomes. In addition it was never
observed uniformly or even in a patchy distribution throughout
the whole of the plasma membrane itself.
In natural infections, parasitaemias are generally pleomorphic
with rapidly dividing slender forms that predominate in the
ascending parasitaemia and short-stumpy forms in the descending
parasitaemia [26,27,28]. The GPI-PLC was found to have the
same pattern of fluorescence in both long-slender forms in the
monomorphic strain, MITat 1.2 and short-stumpy forms in the
very pleomorphic strain, S-42, but with the patchy nature of the
linear array particularly striking in these short-stumpy forms
(compare Figure 3, panels G and H with Figure 3, panel A).
The YFP-tagged GPI-PLC location is identical to wild type
GPI-PLC detected by immunofluorescence
In order to eliminate any possibility that the location of the GPI-
PLC, determined by fluorescent antibody staining of cells, was due
to an artefact, perhaps caused by reaction with a non-GPI-PLC
epitope in bloodstream forms of T. brucei under the conditions
employed for immunofluorescence, a gene encoding the GPI-PLC
itself, tagged with yellow fluorecent protein (YFP), was introduced
into cells and stably expressed. Its presence was detected by direct
fluorescence of the YFP portion of the fusion protein itself. The
location of the GPI-PLC was found by this alternate method to be
identical to that determined by anti-GPI-PLC antibody staining.
The GPI-PLC-YFP fusion protein was located mainly in the usual
patchy linear array along the flagellum adjacent to the flagellar
attachment zone (Figure 3I).
A much smaller fraction of the fluorescence was found within
one or two small endo-membrane-bound cellular compartments
(Figure 3I marked with arrowheads), anterior to the flagellar
pocket but very close to the pellicular microtubules and the plasma
membrane. The identity of this second compartment remains to
be determined.
This second compartment has an interresting morphology. It is
roughly flask-shaped with either a round or stocking-like body and
a single neck that at one end is directed towards the plasma
membrane. In some views the neck appears to be physically joined
at its end to the plasma membrane. In a few cells this same
location and morphology were also found by immunofluorescence
(Figure 4A-2, see arrowheads). It may be significant that this
structure and location were not found in all cells, whereas the
linear array of the GPI-PLC on the flagellar membrane was a
constant finding in all cells. For example, this second compartment
may be present in only some stage(s) of the cell cycle. Furthermore,
this observation together with its location and attachment to the
plasma membrane may suggest that it is a structure involved in the
assembly of the proteins destined to form the new flagellar
attachment zone. In support of this possibility was the additional
observation, using fluorescence-tagged antibodies, that this second
structure also contained the FAZ1 protein, even though it was not
entirely co-localized with the GPI-PLC (small arrows within the
small lower insets in Figure 4 panels C-2, C-3 & C-4).
Effect of temperature during fixation and the subsequent
presence or absence of detergent on detection of the
VSG, tubulin, ISG-70 and the GPI-PLC
The VSG is the predominant surface protein in bloodstream
form trypanosomes and forms the outermost surface of these cells,
even shielding other exterior proteins. The VSG was evenly
distributed over the entire surface of the trypanosome as reported
previously by others [10,29] and was visible when fixed, at either
0uCo r3 7 uC in both the presence and absence of triton X-100
(Figure 5, panels A–D).
Tubulin is the major protein of microtubules in the trypano-
somal cytoskeleton and is found as a pellicular array attached to
the cytoplasmic face of the plasma membrane and as the flagellar
axoneme enclosed by the flagellar plasma membrane. Therefore,
mouse monoclonal IgG anti-a-tubulin (DM1A) antibody [30],
followed by Alexa 488-conjugated anti-mouse IgG, identifies both
the position of the inner-most surface of the plasma membrane of
the cell body, as well as the axonemal portion of the flagellar
compartment. However, this antibody combination detected
tubulin in trypanosomes only when 0.1% triton X-100 was
present during the blocking and antibody treatment steps
regardless of whether trypanosomes were previously fixed at
either 0uCo r3 7 uC (Figure 5, panels A & C) and failed to detect
tubulin in the absence of triton X-100 (Figure 5, panels B & D).
The distribution of tubulin was found to produce a uniform
fluorescence from FITC-labelled anti-tubulin along the inner
surface of the cell body as well as along the central portion of the
flagellum.
Figure 2. The GPI-PLC can be surface radio-iodinated in
bloodstream form trypanosomes. Autoradiographs (15 day expo-
sure) of the immunoprecipitates of the GPI-PLC in non-penetrating
surface radio-iodinated GPI-PLC
+/+ bloodstream forms (4.2610
7 cell
equivalents per track) of T.brucei using either 95 mg of purified non-
immune IgG with GPI-PLC
+/+ (track 1), or using 77.8 mg of anti-GPI-PLC
IgG to compare GPI-PLC
2/2 (track 2) and GPI-PLC
+/+ (track 3)
bloodstream forms of T. brucei.
doi:10.1371/journal.ppat.1000468.g002
the protein sequence of the GPI-PLC the peptides detected are underlined. The symbol * above a lysine (k) represents either an unblocked lysine
within the detected peptide or an unblocked lysine immediately preceeding the detected peptide, after which trypsin has successfully cleaved. The
symbol { above a lysine (k) represents a position within the sequence that has not yet been determined by MALDI-TOF MS to be un-derivatized.
doi:10.1371/journal.ppat.1000468.g001
GPI-PLC Location Before and After Activation
PLoS Pathogens | www.plospathogens.org 4 June 2009 | Volume 5 | Issue 6 | e1000468Figure 3. Confocal images of the GPI-PLC in GPI-PLC
+/+, GPI-PLC
2/2and procyclic form trypanosomes and the YFP-tagged GPI-PLC
in recombinant bloodstream form cells. Each of the panels, A–E, contains a merged image of the nucleus and kinetoplast, together with the GPI-
PLC probed with anti-GPI-PLC antibody (magenta) and the phase image; (panel A), wild-type GPI-PLC
+/+ bloodstream form trypanosome; (panel B), a
GPI-PLC
2/2 null mutant bloodstream form trypanosome; (panel C), a wild-type procyclic form trypanosome; (panel D), a low power view of wild-type
GPI-PLC
+/+ bloodstream form trypanosomes and (panel E), a low power view of GPI-PLC
2/2 null mutant bloodstream form trypanosomes. The phase
image (panel F) of S-42 stumpy bloodstream forms shows the typical morphology of these forms in this strain, while the fluorescence image (panel G)
shows the location of the GPI-PLC (magenta) and the merge of these two images shows their spatial relationship (panel H). The location of YFP-
tagged GPI-PLC is shown in the composite image of six bloodstream forms in panel I and the arrowheads point to the endo-membrane-bound spaces
containing a small amount of GPI-PLC. Bars, 5 mm.
doi:10.1371/journal.ppat.1000468.g003
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disposed integral membrane glycoprotein, present only in
bloodstream forms, and is found in a patchy distribution over
the entire surface of the plasma membrane covering both the cell
body and flagellum. The VSG from a number of different variants
masks the presence of ISG-70 in live but not in fixed cells [31].
Probing fixed trypanosomes with purified polyclonal rabbit anti-
ISG-70 primary antibody followed by Cy-3-labelled goat anti-
rabbit IgG secondary antibody identifies the area of the outer
leaflet of the plasma membrane shielded by the VSG. ISG-70 was
found distributed over the entire surface in an irregular, patchy
pattern when cells were fixed at 0uC, in both the presence and
absence of triton X-100 (Figure 5, panels A & B). However,
fluorescence was absent when trypanosomes were fixed at 37uC
(Figure 5, panels C & D) in both the presence and absence of triton
X-100.
The GPI-PLC was detected by rabbit polyclonal IgG anti-GPI-
PLC, followed by Cy-3-conjugated goat anti-rabbit IgG, in cells
fixed at 0uC (Figure 5, panels A and B), while fixation at 37uC
resulted in no detectable fluorescence (Figure 5, panels C and D).
Detection of the GPI-PLC was insensitive to the presence or
absence of detergent. Clearly, the ability to detect the GPI-PLC
follows the pattern displayed by ISG-70 with respect to
temperature and detergent and does not resemble the pattern
shown by either the VSG or tubulin, suggesting that the GPI-PLC
is located in a restricted portion of the outer leaflet of the plasma
membrane and at least partially shielded by the VSG in the same
manner as ISG-70
Comparative localization of the GPI-PLC and tubulin
In order to verify that the GPI-PLC was not localized to the
inner face of the plasma membrane, its location with respect to
tubulin was investigated. The distribution of tubulin was found to
produce an intense fluorescence due to the large numbers and
regular disposition of the subpellicular microtubules. The
flagellum was seen as a fluorescent, wavy line along the side of
the cell body, due to the microtubules of the flagellar axoneme
(Figure 4, panel A, images 3 & 4). The GPI-PLC was found
distributed between these two regions of microtubules lying closer
to the flagellar axoneme than to the cell body (Figure 4, panel A,
images 2 & 4) and at no point were the two fluorescent dyes co-
localized. Furthermore, the GPI-PLC was distributed along the
Figure 4. Location of the GPI-PLC compared to the location of a series of markers in T. brucei. Each panel shows the comparative
locations of the GPI-PLC (magenta) and a marker; panel A, tubulin marker (cyan); panel B, paraflagellar rod marker (yellow); panel C, FAZ1 protein
marker (orange); panel D, non-penetrating membrane protein reactive dye marker (green). (1), merge of the differential interference contrast image
(DIC) and the Hoechst image of the nucleus and kinetoplast; (2), GPI-PLC; (3), marker; (4), merge of all images in the panel except the DIC image and
(5) is the merge of all images. Arrowheads mark the location of a small amount of the GPI-PLC in a second endomembrane-bound compartment
(Panel A-2). Upper large insets in panels B (4) and C (4) are the adjacent regions in panels B (4) and C (4) respectively with the saturation and
brightness increased. Lower small insets in panels C (2), C (3) and C (4) are the adjacent regions in these panels with the contrast increased in the C (2)
inset for clarity and contain small arrows marking the end of the structure containing both the GPI-PLC and the FAZ1 proteins. Upper arrows mark the
end of the GPI-PLC linear array; lower arrows mark the end of the PFR in panel B (4) and the FAZ1 protein array in panel C (4). Arrowhead in panel C
(4) indicates a region where separation of the FAZ1 protein and the GPI-PLC is particularly clearly demonstrated. Bars, 5 mm.
doi:10.1371/journal.ppat.1000468.g004
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localized to the cell body but, rather, to the flagellar compartment.
A small fraction of the GPI-PLC was also seen in a few cells within
an endo-membrane-bound space close to the inner surface of the
cell anterior to the flagellar pocket (see arrowheads in Figure 4,
panel A, image 2).
Comparative localization of the GPI-PLC and the
paraflagellar rod (PFR)
The paraflagellar rod is a large structure found within the
flagellum of bloodstream form trypanosomes, extending from the
point where the flagellum exits the flagellar pocket, running
alongside the axoneme of the flagellum to its distal tip, and is
physically connected to the axoneme via fibres attaching the
proximal domain to microtubule doublets 4 through 7 [32]. The
crescent shape of the paraflagellar rod and its location between the
axoneme and the flagellar attachment zone in trypanosomes
prompted us to determine the localization of the GPI-PLC
simultaneously with that of the paraflagellar rod.
The pattern of staining using anti-PFR-A confirmed past
observations [32,33]. The paraflagellar rod appeared as a slightly
curved thick linear rod within the flagellar compartment adjacent
to the axoneme, stretching from the lip of the flagellar pocket to
the distal tip of the free flagellum (Figure 4, panel B, images 3 & 4).
The GPI-PLC was detected in the same cells by treatment with
rabbit IgG anti-GPI-PLC, followed by Cy-3-conjugated goat anti-
rabbit IgG, and was found in a patchy, linear array, beginning at a
point close to the lip of the flagellar pocket but slightly more distal
than the proximal end of the paraflagellar rod, to an area just
posterior to the tip of the free flagellum far beyond the end of the
cell body but ending before the distal tip of the paraflagellar rod
(Figure 4, panel B, images 2 & 4 and image 4 inset). The GPI-PLC
was located adjacent to the paraflagellar rod on the side of the rod
facing the cell body in the region where the flagellum is attached to
the cell body (Figure 4, panel B, images 2 & 4). However, the
Figure 5. Effect of temperature and detergent on the detection of the VSG, tubulin, ISG-70 and GPI-PLC. Panel A shows the detection of
VSG, tubulin, ISG-70 and GPI-PLC in wild type bloodstream form trypanosomes fixed at 0uC in the presence of triton X-100. Panel B shows the
detection of VSG, tubulin, ISG-70 and the GPI-PLC in wild type bloodstream form trypanosomes fixed at 0uC in the absence of triton X-100. Panel C
shows the detection of VSG, tubulin, ISG-70 and GPI-PLC in wild type bloodstream form trypanosomes fixed at 37uC in the presence of Tx-100. Panel
D shows the detection of VSG, tubulin, ISG-70 and GPI-PLC in wild type bloodstream form trypanosomes fixed at 37uC in the absence of triton X-100.
The inset in each panel is the Differential Interference contrast (DIC) image. Bars, 5 mm.
doi:10.1371/journal.ppat.1000468.g005
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paraflagellar rod. In fact the merged image (Figure 4, panel B
image 4) shows that the two proteins can be resolved into two non-
overlapping linear structures. This distribution is particularly
striking when the flagellum appears to cross from one side of the
cell body to the other side of the cell body; e.g. when the flagellum,
running along the top of the cell body falls towards one or the
other side of the cell body. In each case the paraflagellar rod lies
furthest from the cell body and the GPI-PLC lies closest to the cell
body (Figure 4, panel B, image 4). This result indicates that the
GPI-PLC is not located in the same position as the paraflagellar
rod but, rather, lies in the region between the paraflagellar rod and
the cell body. Furthermore, the GPI-PLC (Figure 4, upper arrows
in both panel B image 4 and in inset) does not extend along the
free flagellum as far as the paraflagellar rod (Figure 4, lower arrows
in both panel B, image 4 and in inset).
Comparative localization of GPI-PLC and the flagellar
attachment zone protein, FAZ1
The flagellar attachment zone (FAZ) is found in the cytoplasmic
compartment of the cell body, lying adjacent to the paraflagellar
rod, which is in the flagellar compartment, in bloodstream form
trypanosomes [33] and is composed of a number of proteins.
These published images prompted us to determine whether the
GPI-PLC was located in the same compartment as the FAZ,
because we found the GPI-PLC distributed immediately adjacent
to the PFR on the cell body side of PFR (Figure 4, panel B, image
4), which is certainly close to the FAZ region. The fluorescence
observed with mouse monoclonal IgG anti-FAZ1 protein
antibodies (L3B2) followed by Alexa 488-conjugated goat anti-
mouse IgG antibody (Figure 4 panel C images 3 and 4) was found
in a region between the cell body and the flagellum (Figure 4,
panel C, image 4 compare with Figure 4, panel C, image 5). The
GPI-PLC was distributed in the usual patchy linear array along
the outer side of the FAZ (Figure 4, panel C, image 4). The
distribution of both the FAZ and the GPI-PLC begin close to the
flagellar pocket, just anterior to the kinetoplast. However, the GPI-
PLC (Figure 4, panel C, image 4, upper arrow and inset, upper
arrow) extends beyond the distal tip of the FAZ (Figure 4, panel C,
image 4, lower arrow and inset, lower arrow) into the region of the
free flagellum. Even in the regions where both proteins are found,
it is apparent that the GPI-PLC does not co-localize with the
FAZ1 protein (Figure 4, panel C, image 4, arrowhead). The GPI-
PLC was located immediately adjacent to the outer side of the
FAZ on the same side as the flagellum. Combining the information
from the results in Figure 4, panels B and C) one can conclude that
the GPI-PLC lies between the flagellar attachment zone (FAZ) and
the paraflagellar rod (PFR). Therefore, when the flagellum lies on
its side, the FAZ is closest to the cell body and the GPI-PLC is
furthest from the cell body (Figure 4, panel C, image 4). The only
structures that lie between the FAZ and the paraflagellar rod are
the plasma membrane of the cell body and the flagellar plasma
membrane. However, the GPI-PLC only co-localizes with the
proteins of the flagellar plasma membrane and not with the
proteins of the plasma membrane surrounding the cell body
(Figure 4, panel D, image 4). Consequently, we conclude that the
GPI-PLC is located in the flagellar plasma membrane.
Figure 6, panels A & B are presented in order to provide
additional evidence that firstly, the GPI-PLC and the FAZ1
protein are not in the same location and secondly, that the GPI-
PLC is localized to the flagellar membrane of bloodstream form
trypanosomes, while the FAZ1 protein remains with the cell body.
The trypanosomes shown in Figure 6 have been selected because
they are slightly damaged with their flagellum and surrounding
membrane torn from their attachment to the plasma membrane of
the cell body. These images distinguish clearly between the
distribution of the GPI-PLC and the FAZ1 protein. The FAZ1
protein remains attached to the cell body (Figure 6, panel A,
images 2, 4 and 5) while the GPI-PLC remains aligned along the
flagellum (Figure 6, panel B, images 2, 4 and 5). Furthermore, the
Figure 6. The location of GPI-PLC compared to a membrane marker and the FAZ1 protein in cells with a partially detached
flagellum. Panel A shows the comparative location of the FAZ1 protein (orange) and a non-penetrating membrane protein reactive dye (green); (1),
merge of the DIC image and image of the nucleus and kinetoplast; (2), FAZ1 protein; (3), membrane protein; (4), merge of all images in the panel
except the DIC image and (5) is the merge of all images. Panel B shows the comparative location of the GPI-PLC (magenta) and a non-penetrating
membrane protein reactive dye (green); (1), merge of DIC image and image of the nucleus and kinetoplast; (2), GPI-PLC; (3), membrane protein; (4),
merge of all images in the panel except the DIC image and (5) is the merge of all images. The brightness of panel A image 4 and panel B, image 4
have been uniformly increased to the same extent for ease of viewing. Bars, 5 mm.
doi:10.1371/journal.ppat.1000468.g006
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Rather, it occupied a position on the flagellar membrane
immediately adjacent to the cell body (Figure 6, panel B, images
2, 4 and 5).
Comparative localization of GPI-PLC and markers for the
protein and lipid of the plasma membrane
The plasma membrane of bloodstream forms of T. brucei consists
of three distinct but contiguous domains: the pellicular membrane,
the flagellar membrane and the flagellar pocket membrane.
Labeling trypanosomes with a Cy-3-dye conjugated to a
maleimide reactive group, acts as a membrane protein marker
and detects all three plasma membrane domains without labeling
any internal membranes. It appears that the two negatively
charged sulphonate groups and the positively charged quaternary
nitrogen on the dye are sufficient to prevent entry of the dye into
the cell, particularly in the presence of a negative plasma
membrane potential, which excludes net negatively charged
molecules lacking a specific energy-coupled transport system, e.g.
the thiocyanate anion [34]. The cellular distribution of the GPI-
PLC is shown in Figure 4, panel D, images 2, 4 and 5 in an
actively dividing and, consequently, biflagellate cell. It is aligned
along the length of both flagella. The Cy-3 dye has labeled both
the plasma membrane of the cell body and the flagellar membrane
(Figure 4, panel D, images 3, 4 and 5). When the images of the
GPI-PLC and the plasma membrane fluorescence are merged the
resulting image suggests that the GPI-PLC is located on the
membrane of both flagella (Figure 4, panel D, image 4). The
patchy linear distribution of the GPI-PLC localizes along the
exterior portion of the membrane of the flagellum and is nowhere
near the membrane of the cell body. Consequently, it appeared
likely that the GPI-PLC was associated with the flagellar
membrane. A similar result was obtained using the membrane
surface lipid probe, fluorescein-derivatized dihexadecanoyl-glycer-
ophosphoethanol amine [35] in conjunction with rabbit polyclonal
IgG anti-GPI-PLC antibody and a Cy-3 conjugated goat anti-
rabbit IgG secondary antibody (data not shown).
Localization of the activated GPI-PLC after release of the
VSG
An experiment was conducted to determine whether the
activated GPI-PLC moved away from its previous position in the
unactivated state. We have found that incubation of bloodstream
form trypanosomes in the absence of glucose but in the presence of
2-deoxyglucose (10 mM) to de-energize cells and, further, in the
presence of hyperosmotic phosphate - sucrose buffer to prevent cell
rupture, activates the GPI-PLC and quantitatively releases the VSG
over a 45 min time course. The distribution of the GPI-PLC in
trypanosomes that have lost their VSG but are still intact was the
same as it was in fully energized trypanosomes (Compare Figure 7,
panel A, images 2 & 3 with panel B, images 2 & 3). These results
suggest that the GPI-PLC does not move from its location in the
flagellar membrane in order to cleave the GPI anchor of the VSG.
In addition to the confocal microscopic analysis, protein release
from the cell surface was measured (Figure 7, panel C) and the
released protein analyzed by SDS-PAGE and western blotting
(Figure 7, panel D). These results establish that the VSG was
released fromde-energizedtrypanosomeswith a half time of 19 min
(Figure 7, panel C), and converted from mVSG to sVSG as
indicated bythe paradoxical shift inapparentmolecular weight[36]
to an higher value (compare Figure 7, panel D, image 1, lanes a &
b). Furthermore, conversion of the mVSG to the sVSG resulted in
exposure of the CRD epitope on the sVSG, indicating that the
release was due to cleavage of the VSG anchor by the GPI-PLC
(compare Figure 7, panel D, image 2, lanes a & b). Consequently,
release of the VSG occurred when the VSG diffused within the
plane of the membrane to the position of the activated GPI-PLC
and the activated GPI-PLC did not move to the position of each
molecule of the VSG in turn.
Discussion
Experimental results from this study do not support a localization
of the GPI-PLC in the flagellar pocket, in the Golgi, on the
cytoplasmicfaceofintracellularvesicles, inglycosomesorinthe ER,
as previously proposed [14,24,37]. This study does support the
plasma membrane location reported originally by Turner [20].
However, our evidence also demonstrates that the GPI-PLC is
mainly restricted to a small sub-domain of the plasma membrane
covering the flagellum in both long-slender and short stumpy forms.
A small part of the GPI-PLC in some long slender forms but not in
short stumpy forms, is also found in an endo-membrane-bound
space within the cell body, anterior to the flagellar pocket and both
adjacent and connected to the flagellar attachment zone. It is not
present in the plasma membrane of either the flagellar pocket or the
cell body. Instead, it is disposed in a patchy, linear array along the
flagellar membrane adjacent to or within the flagellar attachment
zone, depending upon how this zone is defined. Furthermore, both
thedependenceofthedetectionoftheGPI-PLConthetemperature
of fixation and its independence of the presence of detergent as well
as the results from non-penetrating surface labeling demonstrate
that the enzyme is located in the outer leaflet of the plasma
membrane, consistent with the report by Gruszynski et al. [23].
Importantly, the GPI-PLC remains in the same location, both
before and after activation.
We have estimated the minimum amount of GPI-PLC that could
be detected if present elsewhere in the cell. Clearly, detection
depends upon the amount of material present and the surface area
overwhich itis distributed. The relevant area is the projected area of
the 3-dimensional site being considered, which is less than its true
area because in the projected image, the top surface area is
superimposed upon the lower surface area and the surface area of
the sides are stacked edge-on. Consequently, the projected surface
area is likely to be close to a quarter of the true surface area.
However, the integrated pixel densities in the sum of a series of
confocal slices are also coincident in the projected image. Therefore,
the ratio of integrated pixel density to projected area is the relevant
parameter for confocal microscopy. The area of the projected image
of the GPI-PLC has been found to be 9.8461.54 mm
2 (n=100) in
re-assembled confocal images, while the area of the projected image
of the plasma membrane has been found to be 37.264.7 mm
2
(n=100). The integrated pixel intensity of the GPI-PLC in the
projected image under ideal conditions was 7,226,942.6189. This
value dropped to 427,312.622. in the image that was just visible
when the gain was reduced from 640 v to 580 v in the final stage of
the amplifier circuit. Consequently, if the GPI-PLC were spread
over the entire plasma membrane, the minimum level of detection
would be 22.4% of the amount of GPI-PLC actually detected. In
contrast to this calculation, if the GPI-PLC were spread over the
projected area ofadifferentsite,thentheminimumlevelofdetection
would be a smaller % of that actually observed by a factor of
Apo
Apla
where Apo is the projected area of the site containing the GPI-PLC
and Apla is the projected area of the GPI-PLC itself. Therefore, if the
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PLoS Pathogens | www.plospathogens.org 9 June 2009 | Volume 5 | Issue 6 | e1000468Figure 7. Location of the GPI-PLC in intact cells before and after release of the VSG. Panel A shows a cell in a fully energized trypanosome
incubated for 45 min at 37uC in the presence of glucose (10 mM). Panel B, shows a cell incubated for 45 min at 37uC without glucose but with 2-
deoxyglucose (10 mM) added. In each case panel (1) is a merge of the DIC (gray) and Hoechst stained nucleus and kinetoplast (blue) images, panel (2)
is the GPI-PLC image (magenta) and panel (3) is a merge of all images. Panel C shows the time course of the release of the VSG from bloodstream
form trypanosomes in the absence of glucose but in the presence of 2-deoxyglucose measured as absorbance of the supernatant of cells at 280 nm.
Panel D, image 1 shows the Coomassie blue stained proteins after SDS-PAGE of bloodstream form trypanosomes (MITat 1.1) incubated for 60 min in
the presence of glucose (track a) and in the absence of glucose but with 2-deoxyglucose added (track b). Panel D, image 2 shows an equivalent
western blot. Bars, 5 mm.
doi:10.1371/journal.ppat.1000468.g007
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minimum level of detection would be 2.4% and 3.2% respectively of
the GPI-PLC actually detected, where the projected area of all
glycosomes in the cell was calculated to be 15.8 mm
2 from the total
glycosome area per unit cell volume [38] and the volume of a cell
determined experimentally from [39], converted to projected total
glycosome area by dividing by 4, which arises from the ratio of the
area of a circle (pr
2) divided by the area of a sphere (4pr
2)w h e nb o t h
have the same radius. The projected area of the flagellar pocket was
calculated to be 1.6760.508 mm
2 (n=100) from our own
unpublished data. The way in which all of the preceeding
calculations were performed is documented in the supplementary
material (Text S1).
We have discovered that the temperature of fixation affects the
detection of external, partially buried proteins. This observation
has been used as a novel method to identify such proteins. Analysis
of these temperature and detergent effects provided important
evidence for the location of the GPI-PLC. For example, tubulin is
located exclusively behind the permeability barrier of the plasma
membrane, while the VSG is located on the exterior surface of the
cell and the ISG-70 is located on the exterior surface but shielded
by the VSG. Consequently, tubulin could be detected by
immunofluoresence only when triton was present, while the
VSG and ISG-70 were equally well detected in both the presence
and absence of triton. The GPI-PLC was also detected equally
well in both the presence and absence of triton, strongly suggesting
that it, like the VSG and ISG-70, was located outside the cell.
In contrast to the differential effects of detergent, both tubulin
and the VSG could be seen equally well when fixed at either 0uC
or 37uC. However, detection of both ISG-70 and the GPI-PLC
was strongly affected by the temperature during fixation. Both
proteins were only detected well when cells were fixed at 0uC. Our
interpretation of this finding depended upon the fact that the VSG
partially masks access to underlying proteins on the cell exterior,
which is a major function of the VSG. We reasoned that the VSG
only blocked access of antibodies if it projected beyond underlying
proteins and both diffused rapidly in the plane of the membrane
and bent across shielded proteins at rates similar to those predicted
for inter-bond flexing within proteins, which occur on an infra-red
scale.
Composite results taken from structural studies of both the large
N-terminal folding domain of MITat 1.2 VSG by x-ray
crystallography [40] and its small C-terminal folding domain by
NMR [41] have identified two unstructured, flexible regions
within the peptide chain of the VSG, which may allow bending of
the VSG on the cell surface. These regions comprise the hinge
region (dodecapeptide: QKHKPAESQQQA) between the N- and
C-terminal folding domains and the region at the extreme C-
terminus of the small folding domain (hepadecapeptide:
ETAKDGKTGNTNTTGSS) that links the VSG to its GPI-
anchor. The peptide backbone of these flexible regions are shown
as single lines within the space-filling cartoon of the VSG in
Figure 1 - Scheme 1 panel A, illustrating the orientations that the
VSG folding domains may adopt at 37uC, relative to each other
and to the plane of the membrane, to block access of anti-GPI-
PLC antibodies to the GPI-PLC.
Lowering the temperature from 37uCt o0 uC slows the rates of
both bond flexing and VSG diffusion. Consequently, the VSG
spends short periods as partially coalesced aggregates within the
plane of the membrane and access channels between the VSG
condensates are transiently opened. Covalent fixation of cells at
this lower temperature maintains the VSG in the partially
aggregated condition and the channels of access permanently
open, even if the temperature is subsequently raised, which allows
the anti-GPI-PLC antibodies to reach their target (Figure 8 -
Scheme 1 panel A). On the other hand, fixation of cells at 37uC
allows adjacent molecules of VSG to be covalently linked across
the upper surface of underlying proteins, creating an external
lattice of cross-linked VSG dimers that serves as a permanent
barrier against antibody access to underlying proteins (Figure 8 -
Scheme 1 panel A). In some early experiments we explored the
effect of other, intermediate temperatures of fixation between 0uC
and 37uC on the ability to detect the GPI-PLC and found that it
was a graded effect. Intermediate fixation temperatures gave
image intensities that were detectable but less than that observed
when fixed at 0uC, which would be expected for an effect that
depended on VSG mobility. Further support for the idea that the
temperature dependence of detection of the GPI-PLC is antibody
access dependent comes from the observation that detection of the
innate fluorescence of YFP-tagged GPI-PLC is not temperature
dependent in this manner (data not shown).
This mechanism does not mean that antibodies against surface
proteins, masked by the VSG, bind to their targets at 0uC in live
cells. In the absence of fixative, the VSG on the surface of the cell,
even at 0uC, is still in relatively rapid flux between the partially
aggregated state and the dispersed state and can still bend across
proteins underlying the VSG, preventing antibody binding.
The prediction from immunofluorescence observations that the
GPI-PLC is exposed at the outer surface of the cell was confirmed
by non-penetrating surface labeling with
125I, using the glucose
oxidase/lactoperoxidase method. We have not found it possible to
biotinylate the GPI-PLC under any conditions, even using the
purified recombinant GPI-PLC, which differs from the results of
Gruszynski et al. [23]. However, there was no difficulty in surface
biotinylating other proteins.
The molecular weights of glucose oxidase and lactoperoxidase
are just greater than that of the VSG monomer and 62% of the
VSG monomer respectively, while the atomic weight of the iodide
anion and its free radical are both less than 1/600 of the molecular
weight of the VSG monomer and the molecular weight of H2O2 is
less than 1/1700 of the molecular weight of the VSG monomer.
Consequently, the mechanism preventing anti-GPI-PLC, glucose
oxidase and lactoperoxidase from accessing the GPI-PLC, cannot
prevent access of either the iodide anion and H2O2 or the iodine
free radical, which reacts with tyrosines at the GPI-PLC surface
[42,43].
In cells where the flagellum has detached from the cell body, the
GPI-PLC remains entirely with the flagellum. When this
observation is combined with the information from co-localization
and surface-labelling experiments, it can be safely concluded that
the GPI-PLC is located in the outer leaflet of the flagellar plasma
membrane, disposed in a patchy, linear array along the length of
the flagellar attachment zone and extending into the free flagellum
(Figure 8 - Scheme 1, panel B).
The present study resolves the topological issue that arose when
the enzyme and its substrate were thought to be in separate
compartments. Furthermore, placing the GPI-PLC on the outer
leaflet of the plasma membrane makes the study of the regulation
of the enzyme in situ of current interest. Consequently, the problem
is not, ‘‘How does the GPI-PLC gain access to the VSG?’’ Rather,
the question is, ‘‘What prevents the GPI-PLC from continuously
releasing the VSG under basal conditions?’’ Clearly, the GPI-PLC
must be tightly regulated and its restricted position suggests one
possible mechanism. The GPI-PLC may have its active VSG
binding site occluded by a partner protein under basal conditions
but not under activated conditions. Certainly, the GPI-PLC must
have at least one partner protein linked to the cytoskeleton, in
order for it to be so strictly localized. Furthermore, activation of
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PLoS Pathogens | www.plospathogens.org 11 June 2009 | Volume 5 | Issue 6 | e1000468Figure 8. Scheme 1. Cartoons showing the arrangement of VSG dimers shielding the GPI-PLC at 37uC and allowing access to the GPI-
PLC at 0uC as well as the cross-sectional relationships between the GPI-PLC and other surrounding structures. Panel A. Cartoon of the
arrangement of VSG dimers (red & blue) on the outer leaflet of the plasma membrane of bloodstream form trypanosomes after mild cross-linking (black
bars) of proteins by brief fixation (10 min) at either 37uCo r0 uC. Subsequent access to the VSG is shown by the position of attached IgG anti-VSG (grey,
mauveandturquoise) andaccesstoa partiallyburiedprotein, suchasthe GPI-PLC(mauve),isshown by the positionofattachedorexcludedIgG anti-GPI-
PLC (yellow, green and grey). Panel B. Cartoon of a cross section through the cell body and flagellar compartment showing the relationships between the
GPI-PLC and the flagellar attachment zone together with associated structures, including the ACPSMT, axonemal central pair single mictotubule; APMTD,
axonemal peripheral microtubule doublet; DMT, diminished microtubule [29]; ER, loop of endoplasmic reticulum contacting the four constant
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of Ca
2+ [8,9], while the catalytic activity of the isolated enzyme
itself is independent of Ca
2+ [3] and does not possess a recognized
Ca
2+-binding motif. Consequently, either the partner protein or a
separate regulatory protein may be a Ca
2+-binding protein.
It is unlikely that the GPI-PLC is restricted in position and
regulated by a caging mechanism without binding to a partner
protein. Such a mechanism would require sufficient uncaging
during activation of VSG release for the VSG to diffuse into the
position of the GPI-PLC. Since the GPI-PLC is only 1/3 the size
of a VSG dimer, activation of VSG release by uncaging would also
allow diffusion of the GPI-PLC out of its restricted locale, which
has not been observed. Consequently, it is difficult to reconcile the
restricted location of the GPI-PLC without a direct attachment to
some protein partner that interacts with the cytoskeleton.
The physiological role of the GPI-PLC in all cells is unclear.
Deletion of the gene encoding the GPI-PLC did not exhibit any
striking cellular phenotype in T. brucei [44]. However, there was a
clear infection phenotype that was reversible by returning the gene.
Recently this observation was extended by observing that the double
knock-out of the genes encoding the GPI-PLC and a Zn
2+-
metalloprotease prevented differentiation from bloodstream forms
into procyclic forms and also prevented cell proliferation, while
deletion of either one of these two genes singly was without such an
effect [19]. The possible role of the Zn
2+-metalloprotease in
physiological functions that also involve the GPI-PLC is of interest
for two reasons.
First, differentiation of bloodstream forms into procyclic forms is
accompanied by loss of the VSG and involves both the GPI-PLC
and a protease acting at different times during differentiation. Both
modes of release are independent and occur at the cell surface
[23]. In addition, the VSG can be released by dividing
bloodstream forms in culture, with a half-life of 32 hours [35,45].
Second, treatment of BC3H1 myocytes with insulin also results
in both cleavage of the GPI-anchor from GPI-linked alkaline
phosphatase and proteolytic cleavage of the peptide link between
its two folding domains [46]. Cell signaling via the small C-
terminal peptide , following the sequential action of the protease
and the GPI-PLC, has been suggested but has not been
demonstrated [46,47]. The phosphoinositolglycan has also been
suggested to mediate cell signalling after its release from the GPI-
anchor [48,49] in mammalian cells.
The GPI-PLC has at least one particularly curious feature. It
behaves as an integral membrane protein during purification
[1,3,50], even though it has neither a leader sequence or any
hydrophobic stretch spaning the membrane. Consequently, both
its trafficking mechanism to the exterior and the way it is attached
and remains restricted to a specific region must still be determined.
The GPI-PLC lacks the SH4 domain that is both N- and S-
acylated in the HASPB protein, which is trafficked to the plasma
membrane in Leishmania by a novel non-classical mechanism
[51,52]. It has been suggested that the GPI-PLC is multiply S-
acylated for attachment to the plasma membrane [53] but
acylation does not explain how the GPI-PLC is restricted to a
particular sub-domain of the plasma membrane nor how it is
trafficked to this external location, unless multiple S-acylation,
without the presence of an SH4 domain, also makes the GPI-PLC
a substrate for an HASPB type of translocation.
Materials and Methods
Ethics statement
All animals were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies, and all animal work was approved by the
appropriate committee.
Antibodies
Anti-GPI-PLC IgG and anti-ISG-70 were prepared by the
popliteal lymph node route in rabbits [54] using either
recombinant GPI-PLC [55] or purified ISG-70 [31]. After 3
subcutaneous boosts at 2-week intervals crude anti-sera was
prepared, divided into 3 ml samples, frozen and stored at 220uC.
Rabbit IgG anti-MITat 1.2 VSG was prepared by the procedure
of O’Beirne & Voorheis [56]. All crude anti-sera were purified by
elution from a protein A-Sepharose column [57]. Rabbit anti-
CRD IgG was prepared by immunization with soluble ILTat 1.21
VSG. Cross-reacting antibodies were then eluted after absorption
to MITat 1.6 VSG coupled to cyanogens bromide (CNBr)-
activated Sepharose [58]. Anti-PFR-A and anti-FAZ1 antibody
(L3B2) were kind gifts from Prof. Keith Gull (Sir William Dunn
School of Pathology, University of Oxford, England). Anti-a-
tubulin IgG (Clone DM1A) was obtained from Sigma. Alexa 488-
labeled secondary antibodies were from Invitrogen (Molecular
Probes). Cy-3-labeled secondary antibodies were from Jackson
Immunoresearch.
For immunoprecipitation, protein-A purified rabbit anti-GPI-
PLC IgG (156 mg in 0.02 ml) was bound to Protein A-Sepharose
beads (0.02 ml; 50% v/v; in PBS buffer, pH 7.5, 136 mM NaCl,
3 mM KCl, 16 mM Na2HPO4, 3 mM KH2PO4) by incubation
with rotational mixing overnight at 4uC. The protein A-Sepharose
beads with attached antibody were washed twice with PBS buffer,
pH 7.5, containing 15 mM sodium azide and once with lysis
buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 0.1% NP-40, 0.5%
CHAPS, containing 0.1 mM tosyl-lysine chloromethyl-ketone and
0.3 mM phenylmethylsulphonylfluoride) and finally resuspended
to 0.04 ml (,50% v/v slurry of beads) in lysis buffer.
Generation of the GPI-PLC null mutant
Both alleles of the GPI-PLC gene in the Molteno Institute
trypanosomal antigenic repertoire (MITar) serodeme were deleted
using two constructs in a manner similar to that used previously for
the AnTar serodeme: first, with pLN [44] and second, with pLH,
which was generated by replacing the GPI-PLC gene in p1172kxL
with a hygromycin cassette as a KpnI-Xbal fragment [44].
Bloodstream forms of the MITar serodeme, derived originally
from Lister 427 [59] were grown in culture at 37uC in HMI-9
medium [60], containing 10% (v/v) heat inactivated foetal bovine
serum. These cells were electroporated twice in the presence of
BglI-linearized DNA. First, the cells were brought to hygromycin
resistance using 5 mg pLH in a standard electroporation [44].
Second, after selection using hygromycin (5 mg/ml), the uncloned
population was electroporated in the presence of 5 mg pLN. A
doubly resistant population was selected in the presence of both
hygromycin and G418 (2.5 mg/ml) and then cloned by limiting
dilution. The cloned population stably expressed MITat 1.2 VSG
and was negative for expression of GPI-PLC by Western blotting.
microtubules within the flagellar attachment zone; FAZDB, flagellar attachment zone dense body; GPI-PLC (magenta), the glycosylphospatidyl-inositol
phospholipase C; N, nucleus covered by inner and outer nuclear membranes; PMT, pellicular microtubule; PFR, paraflagellar rod; SCAC, surface coat
coveringtheplasmamembraneoftheflagellarcompartment;SCBC,surfacecoat coveringtheplasmamembraneofthecellbodycompartment;TMF,one
of the transmembrane fibrils connecting the paraflagellar rod to the flagellar attachment zone dense body.
doi:10.1371/journal.ppat.1000468.g008
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The GPI-PLC was expressed as a fusion protein in frame with
YFP at the C-terminus by modifying the endogenous locus in the
GPI-PLC+/2 heterozygote using the method described in [61].
After transfection, cell lines were selected for blasticidin resistance
and the resulting fluorescent clones analysed. All of the several
clones isolated gave similar patterns of fluorescence. For
microscopy, ,1610
6 log phase bloodstream form trypanosomes
were recovered by centrifugation and resuspended in 10 mlo f
0.02% formaldehyde in HMI-9 without serum at 25uC.
Recombinant GPI-PLC-malE fusion protein
The gene encoding the GPI-PLC was amplified by PCR, using
the ‘Expand’ high fidelity DNA polymerase system, from genomic
DNA derived from T. brucei MITat 1.1 using a forward primer (59-
AGG GAT CCT TTG GTG TAA AGT GGT CAC CGC AG-39)
containing a BamH1 restriction site (underlined) and a reverse
primer (59-AGC AAC TCG AGT TAT GAC CTT GCG GTT
TGG TTG GT-39) containing an XHO1 restriction site (under-
lined) and then gel purified. This purified DNA was ligated into the
lacZa gene within the cloning site of the similarly restricted, gel
purified pMBP-parallel2 vector downstream of the malE gene, using
T4 DNA ligase. The vector itself was the kind gift of Dr. Amir
Khan, School of Biochemistry and Immunology, Trinity College
Dublin and had been constructed by replacing the protease site in
the linker fragment of a pMAL-c2 vector (New England Biolabs)
with a tobacco etch virus (TEV) cleavage site. The sequence of the
purified cloned product was found to be correct by DNA
sequencing. The pMBP vector containing the GPI-PLC was
transformed into E. coli BL21(DE3), expressed following addition
of IPTG, and the fusion protein purified first by binding to an
amylose resin column, eluted in the presence of maltose (10 mM),
and then by chromatography on a Sephacryl S-200 column.
Growth and isolation of trypanosomes
Growth, isolation and counting of bloodstream forms of T. brucei
(MITat 1.1) were performed as described previously [62].
Surface labeling
Bloodstream forms of T. brucei (10
8 cells) were surface
radioiodinated (1 mCi carrier-free sodium
125Iodide) using glucose
oxidase (0.66 units) and lactoperoxidase (0.165 units) for 10 min at
25uC as described previously [31] and surface biotinylated (5610
7
cells) using sulfo-N-hydroxy-succinamide long chain spacer arm
(NHS-LC)-biotin (0.3 mg) in a final volume of 1.1 ml for 20 min
at 0–4uC essentially as described by Gruszynski et al. [23].
Immunoprecipitation of GPI-PLC from bloodstream
forms of T. brucei
Trypanosomes (5610
8 cells/ml) were washed twice in TSB
buffer (44 mM NaCl, 5 mM KCl, 3 mM NaH2PO4, 118 mM
sucrose, 10 mM glucose and 0.2 mM adenosine, pH 8). The cell
pellet was resuspended in lysis buffer (50 mM Tris, pH 7.4,
150 mM NaCl, 0.1% NP-40, 0.5% CHAPS, containing 0.1 mM
tosyl-lysine chloromethyl-ketone and 0.3 mM phenylmethylsul-
phonylfluoride) and incubated for 30 min on ice. Cell lysates were
centrifuged at 15,000 g for 15 min and the supernatant collected.
GPI-PLC was immunoprecipitated with anti-GPI-PLC IgG bound
to protein A-Sepharose beads. The immune complexes were
removed from the beads by boiling for 2 min in SDS and their
constituent proteins separated by SDS-PAGE and stained with
Coomassie blue. The protein band corresponding to the GPI-PLC
(,39 kDa) was cut out, the protein passively eluted and
concentrated by a minor modification of the method of Wessel
and Flugge [63], digested with trypsin and analyzed by MALDI-
TOF mass spectrometry. All MS data were acquired using a
Voyager-DE PRO MALDI-TOF mass spectrometer equipped
with a nitrogen laser.
Release of VSG from the surface of bloodstream form
trypanosomes
Trypanosomes (5610
7/ml) were incubated (15 min) in PBS
buffer (NaCl, 136 mM; KCl, 3 mM; Na2HPO4, 16 mM; sucrose,
40 mM; glucose, 10 mM; adenosine, 0.1 mM; pH 7.5) at 37uCi na
final volume of 10 ml with constant gentle stirring to allow any
adsorbed serum proteins to be removed by endocytosis. The
incubation was terminated by adding an excess volume (56)o fi c e -
cold PBS buffer and centrifuging (9,000 g610 seconds at 4uC) in a
minifuge. The pellets were resuspended in ice-cold iso-osmotic
phosphate buffer (Na2HPO4, 20 mM; sucrose, 360 mM; pH 7.5)
containing protease inhibitors (0.3 mM phenylmethylsulphonyl-
fluoride, 0.1 mM tosyl-lysine chloromethyl-ketone, 0.1% (w/v)
leupeptin & 0.2% (w/v) pepstatin), at a final concentration of
5610
8 cells/ml. The cells (5610
8 cells) were then diluted into a
second phosphate buffer without glucose (Na2HPO4,2 0 m M ;
sucrose, 360 mM; pH 8.0) containing the same protease inhibitors
and 2-deoxy-D-glucose (10 mM) at 37uC to give a final cell
concentration of 5610
7/ml and incubated at 37uC for 45 min. The
incubation was terminated by a 10-fold dilution into ice-cold
phosphate buffer (Na2HPO4, 20 mM; sucrose, 360 mM; pH 7.5)
and the cells insamples of the suspension collected bycentrifugation.
The supernatants containing the released VSG were concentrated
by Vivaspin membrane ultra filters (5 kDa cut-off). Both the cell
pellets and the supernatants were subjected to SDS-PAGE and
subsequent western blotting. For confocal microscopy, cells were
fixed for 10 min at 0uC by mixing with equal volumes of fixative in
the same buffer solution at a final concentration of paraformalde-
hyde of 3% (w/v).
Immunofluorescence
Bloodstream form trypanosomes (5610
7 viable cells/ml) were
resuspended in PBS buffer and incubated at 37uC for 20 min with
constant gentle stirring and then a first set of samples were
removed and fixed for 10 min at 37uC with 3% (w/v)
paraformaldehyde final concentration. A second set of samples
were removed and cold quenched immediately by adding an
excess (56) of ice-cold PBS buffer, centrifuged (11,000 g, 2 min,
4uC) and the cells resuspended in PBS buffer and subsequently
fixed for 10 min at 0uC with 3% (w/v) paraformaldehyde.
Procyclic form trypanosomes were fixed for 30 min at 0uC.
Following fixation, cells were washed twice in PBS buffer
containing sodium azide (15 mM) before allowing the cells to
settle on poly-L-lysine coated coverslips surrounded by thin nail
varnish dams. Adherent cells were blocked with PBS containing
5% (w/v) BSA and 0.1 M methylamine, +/20.1% (w/v) triton x-
100 for 1 hr at room temperature. Cover slips with adherent
blocked cells were incubated with the primary antibody in PBS
containing 5% (w/v) BSA, +/20.1% triton X-100 overnight at
room temperature, followed by incubation with the secondary
antibody in 5% BSA for 1 hr at room temperature. After two
washes with PBS, the coverslips were mounted onto slides and
sealed. The mounting media was 50% glycerol in PBS containing
4% (w/v) propylgallate anti-quenching agent. The DNA stain,
Hoechst 33342, was added to the mounting media at 0.1 mg/ml to
visualize the nucleus and kinetoplast.
For visualization of the paraflagellar rod and the FAZ, cells were
settled on poly-L-lysine coverslips and fixed with cold methanol
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(w/v) bovine serum albumin in PBS for 1 hr at room temperature
as described by Sherwin et al. [64].
For labelling the protein in the outer leaflet of the plasma
membrane of bloodstream forms of T. brucei, cells (5610
7 cells/ml)
were incubated for 5 min at 30uC with a Cy-3 protein-reactive
cyanine fluor (Amersham Cat. No. PA23001) that contains two
negatively charged sulphonate groups and one positively charged
quaternary nitrogen to prevent cell entry. Cells were then cold-
quenched with 5 volumes of ice-cold PBS buffer and fixed at 0uC
for 10 min with 3% (w/v) paraformaldehyde.
Primary antibodies and dilutions used were rabbit anti-GPI-
PLC at 1:1000, rabbit anti-VSG at 1:1000, rabbit anti-ISG-70 at
1:500, mouse anti-tubulin at 1:350, mouse anti-PFR-A at 1:50 and
mouse anti-FAZ1 (L3B2) at 1:5. Alexa 488 and Cy-3 -labeled
secondaries were used at 1:1000.
The GPI-PLC was probed with purified polyclonal rabbit anti-
GPI-PLC IgG primary antibody. Tubulin was probed with mouse
monoclonal anti-a-tubulin primary antibody (clone DMIA). The
paraflagellar rod was probed with mouse monoclonal anti-
paraflagellar rod-A IgG primary antibody [33]. The FAZ1 protein
was probed with mouse monoclonal anti-FAZ1 IgG primary L3B2
antibody [33]. MITat 1.2 VSG was probed with purified rabbit
polyclonal anti-MITat 1.2 VSG primary antibody. ISG-70 was
probed with purified rabbit polyclonal anti-ISG-70 IgG antibody.
AllmousemonoclonalIgGprimaryantibodieswerevisualizedusing
Alexa-488-conjugated goat anti-mouse IgG secondary antibody. All
purified rabbit polyclonal IgG primary antibodies were visualized
with Cy-3-conjugated goat anti-rabbit IgG secondary antibody.
Microscopy was performed on an Olympus FV1000 laser
scanning Confocal Microscope, using an UPlanSAPO 606/1.35
NA oil objective. Brightness and contrast adjustments were made to
the whole digital image files and cropping images to size were both
performed using Photoshop 9 (Adobe). Digital blind deconvolution
of multichannel 3D microscopic images was performed with
Bitplane Autodeblur software. Cells were digitally sectioned by
confocal laser scanning fluorescence microscopy at 0.3 mm per slice
and the composite Z-stack of all sections is shown in each figure.
Supporting Information
Figure S1 Specificity of the anti-GPI-PLC antibody for the GPI-
PLC within the recombinant MBP-GPI-PLC fusion protein. The
purified maltose binding protein-GPI-PLC (MBP-GPI-PLC) fusion
protein and the TEV cleaved purified MBP-GPI-PLC fusion
protein wassubjectedto SDS-PAGE (panel A,image 1) and western
blotting (panel A, image 2). In a second experiment, the band
corresponding to the purified fusion protein and that corresponding
to the GPI-PLC, derived by TEV cleavage of the recombinant
immunoprecipitated fusion protein, were cut from the gel, eluted,
trypsin cleaved and subjected to MALDI-TOF MS. Peptides
corresponding to the GPI-PLC derived from the fusion protein are
shown (single underlined) in panel B and gave 50% sequence
coverage of the GPI-PLC. Peptides corresponding to the maltose
binding protein from the fusion protein are also shown (double
underlined) in panel B and gave 51% sequence coverage of the
maltose binding protein. Peptides corresponding to the GPI-PLC,
derived by TEV cleavage of the purified fusion protein, are shown
in panel (C) and gave overall sequence coverage of 23%.
Found at: doi:10.1371/journal.ppat.1000468.s001 (1.01 MB TIF)
Figure S2 Immunoprecipitation of cytoplasmic tubulin in
detergent lysates of surface labelled cells. Pleomorphic populations
of ILTat 1.1 (5610
7 cells/ml) were surface biotinylated and the
excess biotinylation reagent inactivated with 5 mM glycine, cells
detergent-lysed, lysates centrifuged and the clear supernatants
subjected to immunoprecipitation as described in Methods.
Soluble tubulin was removed with anti-tubulin IgG bound to
protein A-Sepharose beads and, following a wash, the immune
complexes were removed by boiling for 2 min in SDS sample
buffer and their constituent proteins separated by SDS-PAGE
followed by Western blotting using (Panel A) anti-tubulin primary
antibody followed by horseradish-conjugated secondary antibody
or (Panel B) horseradish-conjugated streptavidin. In each case lane
1 contains the supernatant of a cell lysate (2610
7 cell equivalents);
lane 2 contains the immunoprecipitated protein (2610
8 cell
equivalents); lane 3 contains the supernatant of the immunopre-
cipitation reaction (2610
8 cell equivalents).
Found at: doi:10.1371/journal.ppat.1000468.s002 (0.17 MB TIF)
Text S1 Supporting information results and figure legends.
Found at: doi:10.1371/journal.ppat.1000468.s003 (0.04 MB
DOC)
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